<DOC>
	<DOCNO>NCT00704951</DOCNO>
	<brief_summary>The purpose program determine frequency use Posaconazole immunocompromised patient refractory first line therapy receive therapeutic treatment base different pathogen comparison antifungal therapy . A objective determine frequency use Posaconazole immunocompromised patient receive prophylactic treatment comparison antifungal prophylaxis .</brief_summary>
	<brief_title>Evaluation Treatment Prophylaxis Invasive Fungal Infections Immuncompromised Patients Austria ( Study P05532 ) ( WITHDRAWN )</brief_title>
	<detailed_description />
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Posaconazole</mesh_term>
	<criteria>Immunocompromised patient refractory IFI Patients eligible prophylactic treatment due anticipate neutropenia 7 day .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>